1.98 USD
+0.01 (+0.51%)
1.98 USD
0 (0%)
Taking everything into account, AIRS scores 2 out of 10 in our fundamental rating. AIRS was compared to 101 industry peers in the Health Care Providers & Services industry. AIRS has a bad profitability rating. Also its financial health evaluation is rather negative. AIRS is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
AIRS had negative earnings in the past year.
AIRS had a positive operating cash flow in the past year.
In multiple years AIRS reported negative net income over the last 5 years.
AIRS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -9.67%, AIRS is not doing good in the industry: 73.27% of the companies in the same industry are doing better.
AIRS has a worse Return On Equity (-21.90%) than 67.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.67% | ||
| ROE | -21.9% | ||
| ROIC | N/A |
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AIRS has a Gross Margin of 63.97%. This is amongst the best in the industry. AIRS outperforms 85.15% of its industry peers.
AIRS's Gross Margin has been stable in the last couple of years.
AIRS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 63.97% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
AIRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AIRS has been increased compared to 1 year ago.
AIRS has more shares outstanding than it did 5 years ago.
AIRS has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.04, we must say that AIRS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.04, AIRS is doing worse than 73.27% of the companies in the same industry.
AIRS has a debt to FCF ratio of 23.08. This is a negative value and a sign of low solvency as AIRS would need 23.08 years to pay back of all of its debts.
The Debt to FCF ratio of AIRS (23.08) is worse than 61.39% of its industry peers.
AIRS has a Debt/Equity ratio of 0.63. This is a neutral value indicating AIRS is somewhat dependend on debt financing.
The Debt to Equity ratio of AIRS (0.63) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 23.08 | ||
| Altman-Z | 1.04 |
ROIC/WACCN/A
WACC9.44%
2.3 Liquidity
AIRS has a Current Ratio of 0.51. This is a bad value and indicates that AIRS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.51, AIRS is not doing good in the industry: 88.12% of the companies in the same industry are doing better.
A Quick Ratio of 0.51 indicates that AIRS may have some problems paying its short term obligations.
The Quick ratio of AIRS (0.51) is worse than 87.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.51 | ||
| Quick Ratio | 0.51 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 7.14% over the past year.
AIRS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.54%.
The Revenue has been growing by 34.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)7.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)-16.54%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-17.76%
3.2 Future
Based on estimates for the next years, AIRS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.40% on average per year.
AIRS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.37% yearly.
EPS Next Y52.4%
EPS Next 2Y24.82%
EPS Next 3Y18.4%
EPS Next 5YN/A
Revenue Next Year-17.19%
Revenue Next 2Y-7.85%
Revenue Next 3Y-3.3%
Revenue Next 5Y2.37%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AIRS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AIRS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AIRS is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as AIRS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.13 | ||
| EV/EBITDA | 31.89 |
4.3 Compensation for Growth
AIRS's earnings are expected to grow with 18.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.82%
EPS Next 3Y18.4%
5. Dividend
5.1 Amount
AIRS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
1.98
+0.01 (+0.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners29.41%
Inst Owner Change1.48%
Ins Owners26.85%
Ins Owner Change0.3%
Market Cap123.63M
Revenue(TTM)157.55M
Net Income(TTM)-17.98M
Analysts76
Price Target6.63 (234.85%)
Short Float %22.75%
Short Ratio2.86
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP-1.32%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)75.51%
Min EPS beat(2)-96.08%
Max EPS beat(2)247.1%
EPS beat(4)2
Avg EPS beat(4)28.68%
Min EPS beat(4)-103.64%
Max EPS beat(4)247.1%
EPS beat(8)3
Avg EPS beat(8)-16.15%
EPS beat(12)4
Avg EPS beat(12)-36.58%
EPS beat(16)5
Avg EPS beat(16)-86.46%
Revenue beat(2)0
Avg Revenue beat(2)-9.13%
Min Revenue beat(2)-13.2%
Max Revenue beat(2)-5.06%
Revenue beat(4)0
Avg Revenue beat(4)-7.84%
Min Revenue beat(4)-13.2%
Max Revenue beat(4)-1.64%
Revenue beat(8)0
Avg Revenue beat(8)-6.26%
Revenue beat(12)2
Avg Revenue beat(12)-3.89%
Revenue beat(16)5
Avg Revenue beat(16)-2.51%
PT rev (1m)0%
PT rev (3m)8.33%
EPS NQ rev (1m)-79.96%
EPS NQ rev (3m)-200%
EPS NY rev (1m)-250%
EPS NY rev (3m)-250%
Revenue NQ rev (1m)-6.19%
Revenue NQ rev (3m)-13.06%
Revenue NY rev (1m)-6.2%
Revenue NY rev (3m)-6.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.78 | ||
| P/FCF | 50.13 | ||
| P/OCF | 14.82 | ||
| P/B | 1.51 | ||
| P/tB | N/A | ||
| EV/EBITDA | 31.89 |
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)0.04
FCFY1.99%
OCF(TTM)0.13
OCFY6.75%
SpS2.52
BVpS1.31
TBVpS-0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.67% | ||
| ROE | -21.9% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 63.97% | ||
| FCFM | 1.57% |
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
F-Score3
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 23.08 | ||
| Debt/EBITDA | 9.48 | ||
| Cap/Depr | 45.53% | ||
| Cap/Sales | 3.73% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 152.38% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.51 | ||
| Quick Ratio | 0.51 | ||
| Altman-Z | 1.04 |
F-Score3
WACC9.44%
ROIC/WACCN/A
Cap/Depr(3y)124.96%
Cap/Depr(5y)109.63%
Cap/Sales(3y)6.83%
Cap/Sales(5y)6.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y52.4%
EPS Next 2Y24.82%
EPS Next 3Y18.4%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.54%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-17.76%
Revenue Next Year-17.19%
Revenue Next 2Y-7.85%
Revenue Next 3Y-3.3%
Revenue Next 5Y2.37%
EBIT growth 1Y-300.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.41%
EBIT Next 3Y12.29%
EBIT Next 5YN/A
FCF growth 1Y-84.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-67.59%
OCF growth 3Y-24.74%
OCF growth 5Y18.1%
AIRSCULPT TECHNOLOGIES INC / AIRS FAQ
What is the fundamental rating for AIRS stock?
ChartMill assigns a fundamental rating of 2 / 10 to AIRS.
What is the valuation status of AIRSCULPT TECHNOLOGIES INC (AIRS) stock?
ChartMill assigns a valuation rating of 1 / 10 to AIRSCULPT TECHNOLOGIES INC (AIRS). This can be considered as Overvalued.
What is the profitability of AIRS stock?
AIRSCULPT TECHNOLOGIES INC (AIRS) has a profitability rating of 2 / 10.
What is the earnings growth outlook for AIRSCULPT TECHNOLOGIES INC?
The Earnings per Share (EPS) of AIRSCULPT TECHNOLOGIES INC (AIRS) is expected to grow by 52.4% in the next year.
Can you provide the dividend sustainability for AIRS stock?
The dividend rating of AIRSCULPT TECHNOLOGIES INC (AIRS) is 0 / 10 and the dividend payout ratio is -1.32%.